Live Breaking News & Updates on Therapeutics Company Profile|Page 3
Stay updated with breaking news from Therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned an average rating of “Hold” from the thirteen ratings firms that are currently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective […] ....
HC Wainwright reaffirmed their buy rating on shares of G1 Therapeutics (NASDAQ:GTHX – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $9.00 price objective on the stock. Several other research analysts have also issued reports on GTHX. Needham & Company LLC reissued a buy rating […] ....
Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX – Get Free Report) fell 9.4% on Tuesday . The company traded as low as $18.52 and last traded at $18.90. 48,484 shares were traded during trading, a decline of 80% from the average session volume of 242,179 shares. The stock had previously closed at $20.86. Analyst Upgrades and […] ....
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0% on Tuesday . The company traded as low as $54.55 and last traded at $55.22. 289,644 shares were traded during trading, a decline of 83% from the average session volume of 1,700,684 shares. The stock had previously closed at $55.24. Wall Street Analysts […] ....
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $84.00 in a report issued on Thursday morning, Benzinga reports. Citigroup currently has a buy rating on the stock. Several other research firms have also recently weighed in on CRSP. TheStreet upgraded shares of CRISPR Therapeutics from a d+ […] ....